Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema

J Anderson, N Maina - Clinical and Translational Allergy, 2022 - Wiley Online Library
Background Hereditary angioedema (HAE), a rare disease that is characterized by painful
and recurring non‐allergic swelling episodes, is caused by the deficiency or dysfunction of …

The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency

J Jacobs, T Neeno - Postgraduate Medicine, 2021 - Taylor & Francis
The majority of angioedema cases encountered in clinical practice are histamine-mediated
(allergic); however, some cases are bradykinin-related (non-allergic) and do not respond to …

Hereditary angioedema in children and adolescents–A consensus update on therapeutic strategies for German‐speaking countries

V Wahn, W Aberer, E Aygören‐Pürsün… - Pediatric Allergy and …, 2020 - Wiley Online Library
Abstract Background/Methods At a consensus meeting in August 2018, pediatricians and
dermatologists from German‐speaking countries discussed the therapeutic strategy for the …

Recognition and management of hereditary angioedema: best practices for dermatologists

ME Manning - Dermatology and Therapy, 2021 - Springer
Objective The goal of this article is to discuss the importance of differentiating hereditary
angioedema (HAE) from other types of angioedema, describe advances in HAE …

Interventions for the long‐term prevention of hereditary angioedema attacks

N Beard, M Frese, E Smertina, P Mere… - Cochrane Database …, 2022 - cochranelibrary.com
Background Hereditary angioedema (HAE) is a serious and potentially life‐threatening
condition that causes acute attacks of swelling, pain and reduced quality of life. People with …

Characteristics and drug utilization of patients with hereditary angioedema in Italy, a real-world analysis

E Giacomini, M Leogrande, V Perrone, M Andretta… - Healthcare, 2023 - mdpi.com
This real-world analysis investigated the characteristics and treatment patterns of patients
with hereditary angioedema (HAE) in Italy using the administrative data of health units …

[HTML][HTML] Preventive treatment of hereditary angioedema: a review of phase III clinical trial data for subcutaneous C1 inhibitor and relevance for patient management

JB West, K Poarch, WR Lumry - Clinical Therapeutics, 2021 - Elsevier
Purpose Hereditary angioedema (HAE), most often caused by a genetically mediated
deficiency in the activity of C1 inhibitor (C1INH) protein, is characterized clinically by …

Lanadelumab for the treatment of hereditary angioedema

MA Wu - Expert Opinion on Biological Therapy, 2019 - Taylor & Francis
Introduction: Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare
yet still probably underdiagnosed clinical condition. Recurrent episodes of subcutaneous …

Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience

K Baynova, S Cimbollek, J Quiralte… - Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life
Experience Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema …

Hereditary Angioedema: Diagnosis, Pathogenesis, and Therapy

AP Kaplan - Current Treatment Options in Allergy, 2022 - Springer
Abstract Purpose of Review This review will focus on our current understanding of the
pathogenesis of hereditary angioedema (HAE) and its therapy. HAE is classically meant to …